Document Type : Research Paper
Authors
1 Department of Microbiology, College of Veterinary Medicine, University of Thi-Qar, Thi-Qar, Iraq,
2 Department of Microbiology, College of Veterinary Medicine, University of Basrah, Basrah, Iraq
3 Department of Microbiology, College of Medicine, University of Basrah, Basrah, Iraq
Abstract
Bacteriophages, recovered from sewage samples target E. coli O157:H7, were tested for their biokinetic and morphological characteristics. Bacterial lysis profile of isolated phages was performed using Escherichia coli O157:H7 (NCTC) 12900 as host bacterial cell. Morphological characteristics of phages were visualized by transmission electron microscopy. The multiplicity of infection (MOI) and biokinetic properties, particularly adsorption rate, rise period, latent period, and burst size were also calculated. Electron microscopy revealed that the isolated phages P1and P3 belong to the Siphoviridae family while the P4 phage belongs to Myoviridae; similar to other E. coli O157:H7-specific phages previously isolated. MOI of P1 was 0.01, while P3 and P4 were 0.1 phage/bacterium. These typical MOI yielding the higher titer of phage were used in the next phage tests. The adsorption curve of the P1 phage was reached a 100% adsorption rate after 25 min of host exposure. Whereas P3 and P4 were taken 35 and 30 minutes, respectively to achieve the same adsorption rate. An implication of this is used in efficient biocontrol strategies for elimination of this bacterial pathogen from their reservoirs (cattle) as well as in the food industry.
Keywords
2. Majowicz SE, Scallan E, Jones-bitton A, Jan M, Stapleton J, Angulo FJ, et al. Global Incidence of Human Shiga Toxin-Producing Escherichia coli Infections and Deaths: A Systematic Review and Knowledge Synthesis. Foodborne Pathog Dis. 2015;11(6):447-55.https://doi.org/10.1089/fpd.2013.1704
3. Summers WC. The strange history of phage therapy. Bacteriophage. 2012;2(2):130-3.https://doi.org/10.4161/bact.20757
4. Rios AC, Moutinho CG, Pinto FC, Del Fiol FS, Jozala A, Chaud MV, et al. Alternatives to overcoming bacterial resistances: State-of-the-art. Microbiol Res. 2016;191:51-80.https://doi.org/10.1016/j.micres.2016.04.008
5. Moghadam MT, Amirmozafari N, Shariati A, Hallajzadeh M, Mirkalantari S, Khoshbayan A, et al. How phages overcome the challenges of drug resistant bacteria in clinical infections. Infect Drug Resist. 2020;13:45-61.https://doi.org/10.2147/IDR.S234353
6. Abdulamir AS, Jassim SAA, Bakar FA. Novel approach of using a cocktail of designed bacteriophages against gut pathogenic E. coli for bacterial load biocontrol. Ann Clin Microbiol Antimicrob. 2014;13(30):1-11.https://doi.org/10.1186/s12941-014-0039-z
7. Dissanayake U, Ukhanova M, Moye ZD, Sulakvelidze A, Mai V. Bacteriophages Reduce Pathogenic Escherichia coli Counts in Mice Without Distorting Gut Microbiota. Front Microbiol. 2019;10(September):1-13.https://doi.org/10.3389/fmicb.2019.01984
8. Morris JL, Letson HL, Elliott L, Grant AL, Wilkinson M, Hazratwala K, et al. Evaluation of bacteriophage as an adjunct therapy for treatment of peri-prosthetic joint infection caused by Staphylococcus aureus. PLoS One. 2019;14(12):1-19.https://doi.org/10.1371/journal.pone.0226574
9. Waters EM, Neill DR, Kaman B, Sahota JS, Clokie MRJ, Winstanley C, et al. Phage therapy is highly effective against chronic lung infections with Pseudomonas aeruginosa. Thorax. 2017;72(7):666-7.https://doi.org/10.1136/thoraxjnl-2016-209265
10. Jassim SAA, Limoges RG. Bacteriophages: Practical Applications for Nature's Biocontrol. 2017.https://doi.org/10.1007/978-3-319-54051-1
11. Abedon ST. Phage therapy dosing: The problem(s) with multiplicity of infection (MOI). Bacteriophage. 2016;6(3):e1220348.https://doi.org/10.1080/21597081.2016.1220348
12. Stone E, Campbell K, Grant I, McAuliffe O. Understanding and exploiting phage-host interactions. Viruses. 2019;11(6):1-26.https://doi.org/10.3390/v11060567
13. Fan N, Qi R, Yang M. Isolation and characterization of a virulent bacteriophage infecting Acinetobacter johnsonii from activated sludge. Res Microbiol. 2017;168(5):472-81.https://doi.org/10.1016/j.resmic.2017.01.006
14. Seeley HW, VanDemark PJ, Lee JJ. Microbes in action: a laboratory manual of microbiology. 4th ed. W. H. Freeman and Company, New York; 2001.
15. Sambrook J, Russel DW. Molecular Cloning: A Laboratory Manual. 3rd ed. Cold Spring Harbor Laboratory Press, New York; 2001.
16. Hyman P. Phages for phage therapy: Isolation, characterization, and host range breadth. Pharmaceuticals. 2019;12(1).https://doi.org/10.3390/ph12010035
17. García R, Latz S, Romero J, Higuera G, García K, Bastías R. Bacteriophage Production Models: An Overview. Front Microbiol. 2019;10(June):1-7.https://doi.org/10.3389/fmicb.2019.01187
18. Durmaz E, Higgins D, Klaenhammer T. Molecular characterization of a second abortive phage resistance gene present in Lactococcus lactis subsp. lactis ME2. J Bacteriol. 1992;174(22):7463-9.https://doi.org/10.1128/jb.174.22.7463-7469.1992
19. Manohar P, Tamhankar AJ, Lundborg CS, Nachimuthu R. Therapeutic characterization and efficacy of bacteriophage cocktails infecting Escherichia coli, Klebsiella pneumoniae, and Enterobacter species. Front Microbiol. 2019;10(MAR):1-12.https://doi.org/10.3389/fmicb.2019.00574
20. Walker PJ, Siddell SG, Lefkowitz EJ, Mushegian AR, Dempsey DM, Dutilh BE, et al. Changes to virus taxonomy and the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses (2019). Arch Virol. 2019.https://doi.org/10.1007/s00705-019-04306-w
21. Abedon ST, Yin JQ. Impact of spatial structure on phage population growth. In: Abedon ST, editor. Bacteriophage Ecology: Population Growth, Evolution, and Impact of Bacterial Viruses. Cambridge; New York: Cambridge University Press; 2008. p. 94-113.https://doi.org/10.1017/CBO9780511541483.007
22. Niu YD, Johnson RP, Xu Y, McAllister TA, Sharma R, Louie M, et al. Host range and lytic capability of four bacteriophages against bovine and clinical human isolates of Shiga toxin-producing Escherichia coli O157:H7. J Appl Microbiol. 2009;107(2):646-56.https://doi.org/10.1111/j.1365-2672.2009.04231.x
23. Barkocy-Gallagher GA, Arthur TM, Rivera-Betancourt M, Nou X, Shackelford SD, Wheeler TL, et al. Seasonal prevalence of Shiga toxin-producing Escherichia coli, including O157:H7 and non-O157 serotypes, and Salmonella in commercial beef processing plants. J Food Prot. 2003;66:1978-86.https://doi.org/10.4315/0362-028X-66.11.1978
24. Ackermann HW, Petrow S, Kasatiya SS. Unusual bacteriophages in Salmonella newport. J Virol. 1974;13:706-11.https://doi.org/10.1128/jvi.13.3.706-711.1974
25. Ackermann HW, Nguyen TM. Sewage coliphages studied by electron microscopy. Appl Environ Microbiol. 1983;45(3):1049-59.https://doi.org/10.1128/aem.45.3.1049-1059.1983
26. Castillo D, Christiansen RH, Dalsgaard I, Madsen L, Middelboe M. Bacteriophage resistance mechanisms in the fish pathogen Flavobacterium psychrophilum: Linking genomic mutations to changes in bacterial virulence factors. Appl Environ Microbiol. 2015;81(3):1157-67.https://doi.org/10.1128/AEM.03699-14
27. Hyman P, Abedon ST. Bacteriophage host range and bacterial resistance. Adv Appl Microbiol. 2010;70:217-48.https://doi.org/10.1016/S0065-2164(10)70007-1
28. Moldovan R, Chapman-McQuiston E, Wu XL. On kinetics of phage adsorption. Biophys J. 2007;93(1):303-15.https://doi.org/10.1529/biophysj.106.102962
29. Kim SG, Jun JW, Giri SS, Yun S, Kim HJ, Kim SW, et al. Isolation and characterisation of pVa-21, a giant bacteriophage with anti-biofilm potential against Vibrio alginolyticus. Sci Rep. 2019;9(1):1-10.https://doi.org/10.1038/s41598-019-42681-1
30. Kim EJ, Chang HJ, Kwak S, Park JH. Virulence factors and stability of coliphages specific to Escherichia coli O157:H7 and to Various E. coli infection. J Microbiol Biotechnol. 2016;26(12):2060-5.https://doi.org/10.4014/jmb.1609.09039
31. Park M, Lee JH, Shin H, Kim M, Choi J, Kang DH, et al. Characterization and comparative genomic analysis of a novel bacteriophage, SFP10, simultaneously inhibiting both Salmonella enterica and Escherichia coli O157:H7. Appl Environ Microbiol. 2012;78(1):58-69.https://doi.org/10.1128/AEM.06231-11
32. Li S, Liu L, Zhu J, Zou L, Li M, Cong Y, et al. Characterization and genome sequencing of a novel coliphage isolated from engineered Escherichia coli. Intervirology. 2010;53(4):211-20.https://doi.org/10.1159/000299063
33. Lu Z, Breidt F. Escherichia coli O157:H7 bacteriophage F241 isolated from an industrial cucumber fermentation at high acidity and salinity. Front Microbiol. 2015;6(FEB):1-10.https://doi.org/10.3389/fmicb.2015.00067
34. Foschino R, Perrone F, Galli A. Characterization of two virulent Lactobacillus fermentum bacteriophages isolated from sour dough. J Appl Bacteriol. 1995;79(6):677-83.https://doi.org/10.1111/j.1365-2672.1995.tb00954.x
35. Chang H, Chen C, Lin J, Shen G, Chang K, Tseng Y, et al. Isolation and characterization of novel giant. Society. 2005;71(3):1387-93.https://doi.org/10.1128/AEM.71.3.1387-1393.2005
36. Raya RR, Varey P, Oot RA, Dyen MR, Callaway TR, Edrington TS, et al. Isolation and characterization of a new T-even bacteriophage, CEV1, and determination of its potential to reduce Escherichia coli O157:H7 levels in sheep. Appl Environ Microbiol. 2006;72(9):6405-10.https://doi.org/10.1128/AEM.03011-05
37. Shahrbabak SS, Khodabandehlou Z, Shahverdi AR, Skurnik M, Ackermann HW, Varjosalo M, et al. Isolation, characterization and complete genome sequence of Phaxi: A phage of Escherichia coli O157:H7. Microbiol. 2013;159(8):1629-38.https://doi.org/10.1099/mic.0.063776-0
38. Viscardi M, Perugini AG, Auriemma C, Capuano F, Morabito S, Kim KP, et al. Isolation and characterization of two novel coliphages with high potential to control antibiotic resistant pathogenic Escherichia coli (EHEC and EPEC). Int J Antimicrob Agents. 2007;31:152-7.https://doi.org/10.1016/j.ijantimicag.2007.09.007
39. Schuster GS, Dirksen TR, Ciarlone AE, Burnett GW, Reynolds MT, Lankford MT. Anticaries and antiplaque potential of free fatty acids in vitro and in vivo. Pharmacol Ther Dent. 1980;5(1-2):25-33.
)
